Navigation Links
XTL Biopharmaceuticals Ltd. Announces $9.6 Million Private Placement to Institutional Investors
Date:10/25/2007

the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Risk factors that could adversely affect our operations are identified from time to time in our reports filed with the Securities and Exchange Commission and the London Stock Exchange, including our annual report on Form 20-F filed with the Securities and Exchange Commission on March 23, 2007. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not intend to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available at http://www.xtlbio.com. The information in our website is not incorporated by reference into this press release and is included as an inactive textual reference only.


'/>"/>
SOURCE XTL Biopharmaceuticals Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- Dyadic International, Inc. (Pink Sheets: DYAI) ("Dyadic") ... with The Scripps Research Institute ("Scripps") by entering ... genome of Dyadic,s patented and proprietary C1 fungus ... the successful relationship between the two organizations which ... to annotate the C1 genome for the first ...
(Date:12/14/2009)... N.J., Dec. 14 The third edition ... , published by the Infusion ... treatment for anthracycline extravasation.(1) Anthracyclines are a ... and epirubicin that have been used in the ... early 1970s.(2) ,, According to the ...
(Date:12/14/2009)... -- Lionbridge (Nasdaq: LIOX ) today ... three-year master services agreement with a multi-billion ... that serve patients in approximately 100 countries. ... sole provider for translation of the company,s ... human resources, legal, and corporate communications information. ...
(Date:12/14/2009)... Decision Resources, one of the world,s ... healthcare issues, finds that, owing to the launches ... market will increase more than sevenfold from $790 ... in the United States, France, Germany, Italy, Spain, ... Pharmacor report entitled Atrial Fibrillation finds ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2
... Celsis In Vitro Technologies (Celsis,IVT), a division ... and laboratory services company, and Wisconsin-based Promega Corp,will ... testing in primary,hepatocytes. Celsis IVT is pre-qualifying ... Promega,s bioluminescent ADME-Tox assays, including,the P450-Glo(TM) CYP Assay ...
... Clinical and Economic Value of Pharmaceuticals in a ... Pharma today announced the start of the first ... for the Pharmaceutical Industry at the Loews Philadelphia ... marketers with strategic insights needed to prepare for ...
... Sleep Apnea Among Insomnia PatientsALBUQUERQUE, N.M., Feb. 9 ... a grant to study one of the most controversial ... psychological factors -- stress, racing thoughts, and worries -- ... therapy. Pitted against the CW is the provocative ...
Other Biology Technology:Celsis In Vitro Technologies and Promega to Offer Fast, Reliable Solutions for ADME-Tox Testing With Primary Hepatocytes 2Celsis In Vitro Technologies and Promega to Offer Fast, Reliable Solutions for ADME-Tox Testing With Primary Hepatocytes 3ExL Pharma Presents The Pharmaceutical Managed Markets Insight & Marketing for the Pharmaceutical Industry Conference 2ExL Pharma Presents The Pharmaceutical Managed Markets Insight & Marketing for the Pharmaceutical Industry Conference 3Controversial Study to Test Link Between Insomnia and Sleep Apnea 2
(Date:12/16/2009)... inhabited our planet for more than 4 billion years ... by as many eons more. That suggests they may ... Tel Aviv University bacteria expert Prof. Eshel Ben-Jacob of ... Astronomy, grounded in the study of bacteria, presents compelling ... most people should not automatically opt for the swine ...
(Date:12/16/2009)... Maryland School of Medicine researcher will lead the coordinating ... scientists in the field of stem cell research. Michael ... was chosen by the National Heart, Lung and Blood ... of national experts, which will be called the NHLBI ... funded by a $30 million grant over seven years. ...
(Date:12/16/2009)... GestureTek Inc. today announced the ... a turnkey, portable, plug and play interactive ... and touring promotions. GestureTek is the inventor ... camera-enabled gesture recognition technology for interactive display, ... quality, the CUBE has TUV, CE, CSA ...
Breaking Biology News(10 mins):Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3Elpac Power System Extends Energy Star Portfolio with 65 Watt External Power Supply 54525 1Elpac Power System Extends Energy Star Portfolio with 65 Watt External Power Supply 54525 2Video 3A Schering Plough Announces FDA Approval of SAPHRIS 28R 29 28asenapine 29 for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Ep 54521 1Video 3A Schering Plough Announces FDA Approval of SAPHRIS 28R 29 28asenapine 29 for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Ep 54521 2Video 3A Schering Plough Announces FDA Approval of SAPHRIS 28R 29 28asenapine 29 for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Ep 54521 3Video 3A Schering Plough Announces FDA Approval of SAPHRIS 28R 29 28asenapine 29 for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Ep 54521 4Video 3A Schering Plough Announces FDA Approval of SAPHRIS 28R 29 28asenapine 29 for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Ep 54521 5Video 3A Schering Plough Announces FDA Approval of SAPHRIS 28R 29 28asenapine 29 for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Ep 54521 6Video 3A Schering Plough Announces FDA Approval of SAPHRIS 28R 29 28asenapine 29 for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Ep 54521 7Video 3A Schering Plough Announces FDA Approval of SAPHRIS 28R 29 28asenapine 29 for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Ep 54521 8Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 1Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 2Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 3
... Researchers have discovered the first microRNAs tiny bits ... each of 10 major degenerative muscular disorders, opening doors ... these debilitating, poorly understood, often untreatable diseases. The study, ... of the National Academy of Sciences, was led by ...
... 2007A late-breaking symposium, Colony Collapse Disorder in Honey Bees: ... recently been added to the 55th Annual Meeting of ... in San Diego, December 9-12. The symposium, headed by ... (USDA-ARS), will explore possible factors that may have caused ...
... and University of California-Santa Cruz researcher Hoyt Peckham found ... study that Nichols and Peckham conducted over the course ... on October 17 in the online, open-access journal PLoS ... operations are a greater threat to the survival of ...
Other Biology News:Massive microRNA scan uncovers leads to treating muscle degeneration 2Research shows loggerhead sea turtles threatened by small-scale fishing operations 2
... These handy dispensers save space and ... and other garb. They are the ... parts used in labs, processing and ... charges and the particles they attract. ...
... 2 NaO 7 S 2 Formula Weight: ... Identity: By IR epsilon max (615 nm, ... equal to 60 x 10 3 Loss ... lambda max (H 2 O solution): ...
...
... FP-6500 is the research-grade spectrofluorometer with a ... sensitivity S/N ratio 200 or greater for ... is especially designed to keep in mind ... as kinetics, stopped-flow, titration, or anisotropic measurements. ...
Biology Products: